
Xeris Biopharma Holdings Inc (XERS) last year’s performance of 51.03% is a clear signal for an entertaining trading season.
On Tuesday, Xeris Biopharma Holdings Inc (NASDAQ: XERS) was -0.39% drop from the session before settling in for the closing price of $5.14. A 52-week